The American Society for Clinical Oncology’s Annual Meeting for 2025 is, if nothing else, absolutely overwhelming and ...

In comments posted in response to the Trump administration’s pharma tariff investigation, companies and industry groups ...

BTIG analysts upgraded Doximity, Inc. (NYSE:DOCS)’s stock from “Neutral” to “Buy” with the price objective of $80. The ...

Three small-cap stocks have surged up to 145% in a year with rising retail interest. Strong growth backs the rally, but ...

Looking ahead, green technologies are one of the key focus areas and align with our new innovation strategy, which focuses on ...

The ASX biotech sector dipped slightly in value in May, but stocks such as Medadvisor and Dimerix recorded lusty gains. ...

Antibody drugs that target the PD-1 and VEGF pathways are in the ASCO spotlight, while doctors wrestle with how to use a new ...

There's no reason the U.S. can't pick up the pace to match the global clinical research front-runners without compromising ...

Biopharma Plastics Market. The global biopharma plastics market is projected to grow at a robust CAGR of 11.4% through 2033, ...